4 Articles
4 Articles
Medtronic wins FDA nod for new Simplera Sync CGM
The MiniMed 780G automated insulin delivery system with the Simplera Sync CGM. [Image courtesy of Medtronic]Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the MiniMed 780G. Approval provides more options for users of the automated insulin delivery (AID) system, which can also work with the Guardian 4 sensor. Simplera Sync, a disposable, all-in-one sensor requires no fingersticks or …
New Simplera Sync™ sensor for the MiniMed™ 780G System now FDA approved
Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 21, 2025 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync™ sensor for use with the MiniMed™ 780G system. With this approval, the MiniMed™ 780G system now offers more flexibility for users of the company’s most advanced insulin delivery syst…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage